Figure 1
(A) The overall survival periods of lung cancer patients with low or high expression of USP52 were estimated by Kaplan–Meier plotter (http://kmplot.com). (B) Ten pairs of fresh primary NSCLC tumor tissues (T) and individual normal paracancerous tissues (N) were prepared for qRT-PCR against USP52. (C) Representative images of the IHC staining for USP52 in NSCLC tissues and normal paracancerous tissues. (D) Three NSCLC cell lines and one HBE were prepared for qRT-PCR against USP52. *P<0.05, **P<0.01.
Low expression of USP52 predicts a poor prognosis for NSCLC patients

(A) The overall survival periods of lung cancer patients with low or high expression of USP52 were estimated by Kaplan–Meier plotter (http://kmplot.com). (B) Ten pairs of fresh primary NSCLC tumor tissues (T) and individual normal paracancerous tissues (N) were prepared for qRT-PCR against USP52. (C) Representative images of the IHC staining for USP52 in NSCLC tissues and normal paracancerous tissues. (D) Three NSCLC cell lines and one HBE were prepared for qRT-PCR against USP52. *P<0.05, **P<0.01.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept